Bisphosphonates are the primary therapy for postmenopausal and glucocorticoid-induced osteoporosis. Case series suggest a potential link between prolonged use of bisphosphonates and low-energy fracture of subtrochanteric or diaphyseal femur as a consequence of oversuppression of bone resorption. Usi
✦ LIBER ✦
Trends in subtrochanteric, diaphyseal, and distal femur fractures, 1984–2007
✍ Scribed by A. C. Ng, M. T. Drake, B. L. Clarke, S. A. Sems, E. J. Atkinson, S. J. Achenbach, L. J. Melton III
- Book ID
- 113021078
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 194 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Oral bisphosphonates and risk of subtroc
✍
Seo Young Kim; Sebastian Schneeweiss; Jeffrey N Katz; Raisa Levin; Daniel H Solo
📂
Article
📅
2011
🏛
American Society for Bone and Mineral Research
🌐
English
⚖ 214 KB
Subtrochanteric and Diaphyseal Femur Fra
✍
Bo Abrahamsen; Pia Eiken; Richard Eastell
📂
Article
📅
2009
🏛
American Society for Bone and Mineral Research
🌐
English
⚖ 492 KB
Trends in Incidence of Subtrochanteric F
✍
Zhong Wang; Timothy Bhattacharyya
📂
Article
📅
2011
🏛
American Society for Bone and Mineral Research
🌐
English
⚖ 124 KB
Increasing numbers of atypical hip fractures have been reported among patients with bisphosphonate use. However, the nature and extent of the problem are unknown despite recent investigations. To analyze national trends in hip fractures and medication use in the elderly US population, we respectivel
Secular trends in distal humeral fractur
✍
Mika Palvanen; Pekka Kannus; Seppo Niemi; Jari Parkkari
📂
Article
📅
2010
🏛
Elsevier Science
🌐
English
⚖ 277 KB